M4MM
Cannabis Earnings Outlook Dims as Q2 2025 Looms, Latest Analysis
LOS ANGELES – As the Cannabis industry braces for Q2 2025 earnings releases in early August, a sobering picture emerges from Viridian Capital Advisors’ Chart of the Week. Ten of twelve tracked companies are projected ...
Cash, Crime, and Cannabis: Attorneys General Push Congress on SAFER Banking Act
WASHINGTON, D.C.–In a rare show of bipartisan unity, attorneys general from 32 states and U.S. territories issued a pointed appeal to Congress on Thursday: pass the SAFER Banking Act of 2025 — and finally bring ...
Cresco Labs Exits California Cannabis Market in Bold Strategic Pivot
LOS ANGELES – Cresco Labs Inc. (OTCQX: CRLBF), a multistate cannabis operator, announced its withdrawal from California, the world’s largest cannabis market. This move aligns with the company's broader strategic restructuring aimed at stabilizing its ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Cannabis Earnings Outlook Dims as Q2 2025 Looms, Latest Analysis
LOS ANGELES – As the Cannabis industry braces for Q2 2025 earnings releases in early August, a sobering picture emerges from Viridian Capital Advisors’ Chart of the Week. Ten of twelve tracked companies are projected ...
Cash, Crime, and Cannabis: Attorneys General Push Congress on SAFER Banking Act
WASHINGTON, D.C.–In a rare show of bipartisan unity, attorneys general from 32 states and U.S. territories issued a pointed appeal to Congress on Thursday: pass the SAFER Banking Act of 2025 — and finally bring ...
Cresco Labs Exits California Cannabis Market in Bold Strategic Pivot
LOS ANGELES – Cresco Labs Inc. (OTCQX: CRLBF), a multistate cannabis operator, announced its withdrawal from California, the world’s largest cannabis market. This move aligns with the company's broader strategic restructuring aimed at stabilizing its ...
Germany’s Cabinet Advances Bill to Legalize Recreational Cannabis Amidst Controversy
BERLIN — Germany's cabinet gave the green light to a divisive bill on Wednesday that aims to legalize recreational cannabis use and cultivation, positioning Germany to have one of the most liberal cannabis statutes in ...
Organigram Holdings Partners with 4C LABS to Supply Medical Cannabis to the UK
LOS ANGELES— Organigram Holdings Inc., a recognized licensed producer of cannabis, announced today its strategic expansion into the UK market. The company has inked a supply agreement with 4C LABS, an emerging healthcare, tech, and ...
Cresco Labs Reports Q2 Results Amid Expansion Efforts
LOS ANGELES— Cresco Labs, a Chicago-based cannabis company, disclosed a 9% decline in revenues for the second quarter ended June 30, compared to the same timeframe last year. However, the company registered a modest quarter-on-quarter ...
Ohio Projects Significant Tax Revenues from Potential Cannabis Legalization
LOS ANGELES— Ohio might experience a significant influx in tax revenue from adult-use cannabis sales, estimated between $276.2 million to $403.6 million annually by the fifth year, should voters approve a prospective legalization measure this ...
atai Life Sciences Releases Promising Results from PCN-101 Phase 1 Study, Offering Potential for Home-Based Use
LOS ANGELES-- atai Life Sciences (NASDAQ: ATAI), a pioneering biotech company, has reported encouraging results from its Phase 1 investigation into the subcutaneous administration of PCN-101 (R-ketamine), facilitated through its subsidiary, Perception Neuroscience. The trial's ...
GrowGeneration Corp Reports Mixed Financial Performance Amid Challenging Cannabis Landscape
LOS ANGELES — GrowGeneration Corp., a specialty hydroponic and organic garden center chain with 62 branches across 18 states, announced its financial performance for the second quarter ending June 30, 2023. Key Takeaways: Net Sales: ...
Green Thumb Industries Reports Q2 2023 Financial Performance; Revenue Grows Sequentially
LOS ANGELES— Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), one of the prominent national cannabis consumer packaged goods companies and the proprietor of RISE Dispensaries, revealed its Q2 financial results for the period ending ...
MyMD Pharmaceuticals Receives FDA Approval to Proceed with Investigational Rheumatoid Arthritis Drug
BALTIMORE – MyMD Pharmaceuticals, Inc. announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) Application to study the safety and effectiveness of the oral TNF-α ...
South Dakota Takes Steps Towards Legalization of Cannabis: New Initiative Awaits Public Comment
LOS ANGELES-- South Dakota's path to legalizing cannabis took a notable step forward, as the state's Attorney General Marty Jackley (R) has officially released a draft summary of an initiative to legalize the substance. The ...
MindMed Partners with K2 HealthVentures in $50 Million Credit Facility for Brain Health Research
NEW YORK — Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing innovative solutions for brain health disorders, announced today the signing of a senior secured credit facility with K2 HealthVentures, a leading ...
Columbia Care Reports Q2 Earnings: Revenue Remains Steady as Cost-Cutting Efforts Show Results
NEW YORK — Columbia Care Inc., a player in the cannabis industry, released its financial results for the second quarter ending June 30, 2023, showcasing resilience amid complex market conditions. The numbers reveal slight shifts ...
Glass House Brands Reports Record Second Quarter 2023 Financial Results
LOS ANGELES-- Glass House Brands Inc., a vertically integrated cannabis companies in the U.S., reported its financial results for Q2 2023, ending June 30. The figures reveal a record-breaking quarter for the company, with revenue ...
Michigan Poised to Become a $3 Billion Cannabis Market; July Sales Record Set
LOS ANGELES —Michigan's cannabis market is booming, on pace to reach a significant milestone this year, potentially becoming the nation's second $3-billion market. Licensed dispensaries reported record sales of $276.7 million in July 2023, with ...
Alabama Medical Cannabis Commission Revamps Licensing, Leaving Verano Holdings Out
LOS ANGELES-- The Alabama Medical Cannabis Commission has overhauled its initial round of business licensing, with some of the original winners, including Verano Holdings Inc., ending up on the losing side. The reshuffling has led ...
Mind Medicine Partners with Catalent for Innovative Psychedelic-Based Anxiety Treatment
NEW YORK — Mind Medicine Inc., known as MindMed, has secured a licensing agreement with Catalent to utilize its proprietary Zydis orally disintegrating tablet (ODT) technology for the development of a groundbreaking psychedelic-based anxiety treatment, ...
